172 related articles for article (PubMed ID: 26189009)
21. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
Portnoy A; Jit M; Helleringer S; Verguet S
Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
[TBL] [Abstract][Full Text] [Related]
22. Measles epidemiology and outbreak response immunization in a rural community in Peru.
Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
[TBL] [Abstract][Full Text] [Related]
23. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
[TBL] [Abstract][Full Text] [Related]
24. Accelerated measles control--Cambodia, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
[TBL] [Abstract][Full Text] [Related]
25. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
Fields R; Dabbagh A; Jain M; Sagar KS
Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
[TBL] [Abstract][Full Text] [Related]
26. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Olson ZD; Babigumira JB; Desalegn D; Johansson KA; Kruk ME; Levin CE; Nugent RA; Pecenka C; Shrime MG; Memirie ST; Watkins DA; Jamison DT
Lancet Glob Health; 2015 May; 3(5):e288-96. PubMed ID: 25889470
[TBL] [Abstract][Full Text] [Related]
27. Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia.
Desta T; Lemango E; Wayessa D; Wondowossen L; Kerie M; Masresha B
Pan Afr Med J; 2021; 40():229. PubMed ID: 35145591
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of supplementary immunization for measles in India.
Dabral M
Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
[TBL] [Abstract][Full Text] [Related]
30. Implementing nationwide measles supplemental immunization activities in Ethiopia in the context of COVID-19: process and lessons learnt.
Nigus M; Zelalem M; Abraham K; Shiferaw A; Admassu M; Masresha B
Pan Afr Med J; 2020; 37(Suppl 1):36. PubMed ID: 33456660
[TBL] [Abstract][Full Text] [Related]
31. [Costs and benefits of measles vaccination].
Ambrosch F; Wiedermann G; Harasek G
Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
[TBL] [Abstract][Full Text] [Related]
32. Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
Mohamed N; Simba D; Mphuru A; Lyimo D; Kyesi F
Vaccine; 2020 Nov; 38(49):7741-7746. PubMed ID: 33164797
[TBL] [Abstract][Full Text] [Related]
33. [Cost-effectiveness analysis on two different measles immunization strategies].
Wu H; Wang K; Zhang X; Jin S; Feng Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):121-3. PubMed ID: 11860771
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
35. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
[TBL] [Abstract][Full Text] [Related]
36. The impact of supplementary immunization activities on measles transmission dynamics and implications for measles elimination goals: A mathematical modelling study.
Shen M; Sun X; Xiao Y; Liu Y; Wang C; Wang Z; Rong L; Peng Z
J Theor Biol; 2022 Nov; 551-552():111242. PubMed ID: 35952756
[TBL] [Abstract][Full Text] [Related]
37. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis.
Trentini F; Poletti P; Merler S; Melegaro A
Lancet Infect Dis; 2017 Oct; 17(10):1089-1097. PubMed ID: 28807627
[TBL] [Abstract][Full Text] [Related]
38. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
[TBL] [Abstract][Full Text] [Related]
39. Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001).
Cliff J; Simango A; Augusto O; Van Der Paal L; Biellik R
J Infect Dis; 2003 May; 187 Suppl 1():S51-7. PubMed ID: 12721891
[TBL] [Abstract][Full Text] [Related]
40. Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign.
Bernhardt GL; Cameron NA; Willems B; Boulle A; Coetzee D
S Afr Med J; 2013 Jan; 103(3):181-6. PubMed ID: 23472696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
